You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
|
|---|---|
| Published in |
Cochrane database of systematic reviews, October 2011
|
| DOI | 10.1002/14651858.cd007751.pub2 |
| Pubmed ID | |
| Authors |
Pawana Sharma, Rachel C Blackburn, Claire L Parke, Keith McCullough, Angharad Marks, Corri Black |
| Abstract |
Chronic kidney disease (CKD) is a long term condition that occurs as a result of damage to the kidneys. Early recognition of CKD is becoming increasingly common due to widespread laboratory estimated glomerular filtration rate (eGFR) reporting, raised clinical awareness, and international adoption of Kidney Disease Outcomes Quality Initiative (K/DOQI) classification. Early recognition and management of CKD affords the opportunity not only to prepare for progressive kidney impairment and impending renal replacement therapy, but also for intervening to reduce the risk of progression and cardiovascular disease. Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) are two classes of antihypertensive drugs that act on the renin-angiotensin-aldosterone system. Beneficial effects of ACEi and ARB on renal outcomes and survival in people with a wide range of severity of renal impairment have been reported; however, their effectiveness in the subgroup of people with early CKD (stage 1 to 3) is less certain. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 7 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 162 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Austria | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 159 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 21 | 13% |
| Researcher | 19 | 12% |
| Student > Bachelor | 18 | 11% |
| Student > Ph. D. Student | 15 | 9% |
| Student > Postgraduate | 14 | 9% |
| Other | 28 | 17% |
| Unknown | 47 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 71 | 44% |
| Nursing and Health Professions | 8 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 5% |
| Agricultural and Biological Sciences | 3 | 2% |
| Psychology | 3 | 2% |
| Other | 16 | 10% |
| Unknown | 53 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2021.
All research outputs
#2,064,554
of 25,746,891 outputs
Outputs from Cochrane database of systematic reviews
#4,343
of 13,136 outputs
Outputs of similar age
#9,953
of 145,584 outputs
Outputs of similar age from Cochrane database of systematic reviews
#27
of 129 outputs
Altmetric has tracked 25,746,891 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,136 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 145,584 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 129 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.